Circumvent® PCV

Porcine Circovirus (PCV) associated disease is now recognized as a global, epizootic disease that causes significant economic losses to pig producers. Circumvent PCV is an inactivated vaccine against PCV developed and produced in Desoto in the USA.

Circumvent PCV aids in the prevention of viremia and virus shedding caused by Porcine Circovirus Type 2. Typically two 2ml doses of vaccine are given starting from 3 weeks of age with a 3 week interval.

Using Circumvent PCV

  • Overcomes maternal antibodies.
  • Reduces PCV2 viremia and shedding.
  • Significant reduction in mortality.
  • Significant reduction in morbidity.
  • Reduced medication use/costs.
  • Improved growth performance.

For more information see the Description.